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Idiopathic pulmonary hemorrhage was diagnosed in 37 infants in the Cleveland, Ohio, area
between 1993 and 1998. This rare disorder has been related to 12 deaths, including 7 originally
thought to be sudden infant death syndrome. Thirty of the infants were African American, all of
whom lived in a limited geographic area of eastern metropolitan Cleveland, an area of older
housing stock. An investigation led by the Centers for Disease Control and Prevention has found
an association with household exposure to a toxigenic mold, Stachybotrys chartarum, and other
fungi. The rapidly growing lungs of young infants appear to be especially vulnerable to the toxins
made by toxigenic molds. Environmental tobacco smoke was frequently present in the infants'
homes and may be a trigger precipitating the acute bleeding. Stachybotrys, although not thought
to be a common mold, is known to have a wide geographic distribution. An additional 101 cases of
acute, idiopathic pulmonary hemorrhage have been reported in infants in the United States over
the past 5 years. In this overview, the investigations are summarized, the clinical profile is
described, the toxicity of S. chartarum is discussed, and pathophysiologic concepts are presented.
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Background
Between 1993 and 1998, 37 cases of
pulmonary hemorrhage and hemosiderosis
have been identified in young infants in the
vicinity ofCleveland, Ohio. Twelve of the
infants have died. In November 1994, the
Centers for Disease Control and Prevention
(CDC) began an investigation to determine
the cause of this outbreak (1,2). Thirty of
these cases have occurred within a contigu-
ous nine zip code area in the eastern part of
the metropolitan area. The case-control
study found an association with home water
damage (3) and the presence of the toxi-
genic fungus Stachybotrys chartarum and
other fungi in indoor air. This fungus was
found in higher quantity in the air of the
home environments ofthe affected infants
but also to a lesser degree in some of the
comparison homes (4). Stachybotrysrequires
water-soaked cellulose to grow, and was
found in homes where there had been water
damage from flooding, plumbing leaks, or
roofleaks involving wood or paper products
(e.g., insulation, gypsum board, ceiling tile).
The spores of this fungus contain very
potent mycotoxins capable of producing
acute toxicosis. Secondary stresses, e.g.,
environmental tobacco smoke, appear to be
important triggers of overt hemorrhage.
Since the initial investigation, additional
cases have occurred in Cleveland infants.
The clinical spectrum of this disease
varies from overt, life-threatening hemor-
rhage to very subtle initial symptoms such
as nose bleeds and chest congestion.
Concern that there may be a larger number
ofundetected young infants with this disor-
der led to the examination of all infant
coroner cases over the past 4 years. This
revealed seven sudden infant death syn-
drome cases with major amounts of pul-
monary hemosiderin-laden macrophages,
indicating extensive hemosiderosis existing
prior to death. All but one of these infants
had lived in the same geographic cluster
area in Cleveland.
This problem may extend beyond
Cleveland, as toxigenic fungi are widespread
and chronic water damage is common in
poorly maintained homes throughout the
nation. Informal surveillance (5) has identi-
fied 138 infants with idiopathic pulmonary
hemorrhage in the United States during the
past 5 years. The following is an overview
of the clinical features of the Cleveland
infants with pulmonary hemorrhage, the
results of the field studies, the toxicity of
S. chartarum, and working concepts ofthe
pathogenic mechanisms.
Pulmonary Hemosiderosis
Idiopathic pulmonary hemosiderosis (PH)
is a rare disorder, especially in infants.
Over the 10 years prior to 1993, there had
only been three pediatric cases with this
disorder at Rainbow Babies and Childrens
Hospital, a referral center for all ofnorth-
eastern Ohio. The incidence of PH in
Sweden is 2.4 per 107 children per year
(6) and in Japan it is 1.1 per 106 children
per year (7). Within the limited geo-
graphic cluster area, the Cleveland inci-
dence for 1993-1995 was 1.5 per 1,000
live births. Immune disorders are the most
common etiology of PH in adolescents
and adults (e.g,. Goodpasture's, systemic
lupus erythematosis) but are unlikely to
occur in infants and have never been
reported in children less than 2 years of
age. An association of PH in infants and
young children with elevated IgG precip-
itins against cow milk proteins (Heiner's
syndrome) (8) has been specifically
excluded in this cluster of Cleveland cases
(3). Other causes of PH, such as cardiac
structural disorders giving increased pul-
monary venous pressure, have also been
excluded. In contrast to adult PH, the
majority of PH in infants and children is
idiopathic (9). A retrospective study of30
childhood cases over 20 years in Greece
(10) speculated the possible role of pesti-
cides; other toxicants have been implicated
in older patients (11).
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Isolated acute pulmonary hemorrhage
in infants is probably more frequent than
hemosiderosis and can arise from multiple
causes (e.g., necrotizing pneumonia,
trauma) (12), but prolonged bleeding does
not occur in these cases. Hemosiderosis,
defined as alveolar and/or interstitial
distribution ofhemosiderin-laden macro-
phages, occurring beyond the acute hem-
orrhagic period is evidence for a chronic
bleeding process. Human and animal
studies indicate that hemosiderin-laden
macrophages are cleared from the alveoli
in about 2 weeks (13,14). Thus, to clas-
sify a patient as having hemosiderosis
beyond the repair period of the acute
hemorrhage, bronchoscopy for bron-
choalveolar lavage (BAL) should be per-
formed more than 3 weeks after the initial
bleed. The finding of large quantities of
hemosiderin-laden macrophages in these
BALs defines these patients as having
ongoing bleeding, i.e., hemosiderosis, and
not just isolated hemorrhage.
Investigation of Pulmonary
Hemosiderosis in Cleveland
The initial investigation directed by the
CDC focused on the first 10 cases and 30
age- and geographic-matched control
infants (3,4). All cases were African
American, 9 were male, and none had
been breast-fed. Sixty percent of the cases
experienced recurrent pulmonary hemor-
rhage upon returning to their homes.
(Subsequently, only 12% ofpatients kept
out of their original home environment
have had overt rebleeding.) A 240-item
questionnaire followed by extensive home
environmental surveillance and testing
failed to reveal pesticide exposure or other
potentially related household toxic sub-
stances (3). However, the case infants'
home environments had a higher preva-
lence ofwater damage (odds ratio [OR] =
16.25; 95% confidence interval [Cl]
2.55-oo) and a higher quantity ofairborne
S. chartarum (OR = 9.83; 95% CI 1.08 -
3 x 106)(4). Other, nonspeciated molds,
which may include some toxigenic species,
were also significantly increased as a group
in the case homes. Although Aspergillus,
Cladosporium, and Penicillium were abun-
dant in the case infants' homes, matched
analyses for these molds failed to demon-
strate differences in concentrations between
case and control homes. Because raw
sewage was the source ofwater damage in
only one case home, Gram-negative bacte-
ria and endotoxins were not investigated.
Multivariate matched analysis implicated
exposure to environmental tobacco smoke
as a riskfactor in the presenceofS. chartarum
(OR = 21; 95% CI 1.07 - 7.5 x 106). The
study concluded that infants with pul-
monary hemorrhage and hemosiderosis were
more likely than controls to live in homes
with toxigenic S. chartarum and other fungi
in the indoor air (4).
While 16 of the 28 control homes
investigated had some evidence of S.
chartarum, continued study ofsubsequent
cases showed 20 of 23 tested case homes
were positive. Subsequent analysis of the
Cleveland mold isolates has confirmed
their ability to produce several macrocyclic
trichothecene toxins, including satratoxins
G and H (15). Neither the cytotoxicity or
mycotoxin content of extracts from the
cultured isolates statistically distinguished
between the case and control homes (15).
Mold samples taken directly from the
homes have not been analyzed for myco-
toxins. A highly sensitive assay capable of
detecting trichothecene toxicity in airborne
particulates has been developed for use in
subsequent investigations (16). Further
etiologic correlations will require the devel-
opment ofanalytical techniques capable of
demonstrating the fungal toxins in blood
and/or urine samples from these infants
and the reproduction of the disorder in
infant animals, both ofwhich are goals of
ongoing research.
Why the cluster of cases occurred in a
limited geographic area of Cleveland is
unclear. This is a residential area of pri-
marily wood frame homes, most ofwhich
are more than 60 years old and may be
inadequately maintained (3). The area is a
drainage plain where basements are fre-
quently flooded in heavy rainstorms. The
forced air heating in these homes com-
monly draws air from the entire base-
ment, providing a means for airborne
particulates to be circulated up into the
infants' sleeping areas. Based on the 1990
census (17), the area contains 20% ofthe
county population, 82.2% of the popula-
tion is African American, 48.2% ofall the
children live below the poverty level, and
38.0% ofthese children live with a single,
unemployed parent.
Clinical Profile
ofCleveland Cases
This cluster ofcases in Cleveland has been
limited to infants, all but two of whom
have been <6 months ofage (mean age at
initial hemorrhage =3.1 months). Most of
the 30 patients (excluding the seven cases
diagnosed postmortem) have presented
with respiratory distress (88%) requiring
intensive care (81%), often needing venti-
lator support (73%), usually for several
days, and blood transfusions (50%). Seven
patients developed respiratory failure prior
to any overt signs of hemorrhage, which
became apparent only upon intubation.
Four of these infants were experiencing
clinical events associated with stresses that
usually do not produce respiratory failure,
e.g., anesthesia induction for elective
surgery, hypernatremic dehydration, water
intoxication, and febrile seizure. At least
four infants had overt pulmonary hemor-
rhage associated with apparent upper air-
way obstruction (neck flexion in car seats),
and one patient had a subsequent fatal
hemorrhage while sleeping prone with her
blanket pulled into her face. Non-
pulmonary manifestations have included
neurologic problems (11% with develop-
mental delay and/or failure to thrive, 22%
with seizures), concomitant infection
(19%, including Pneumocystis carinii pneu-
monia), and hemolysis with hemoglobin-
uria (26%). All ofthe patients available for
subsequent bronchoscopy (22 patients)
have had continued hemosiderosis, most
for > 6 months. During this period of
chronic bleeding, 21 patients have been
treated with steroids (prednisone; 1.0
mg/kg/day) for an average of 8.7 months,
although the role ofinflammation in these
infants is not well established. Three ofthe
five patient deaths occurred without the
use of steroids or after stopping them
before the hemosiderosis had completely
resolved. Additional therapy for reactive
airways was required for 39% ofthe infants
for 3-6 months following the pulmonary
hemorrhage. This is twice the incidence of
respiratory illness with wheezing in normal
infants (18).
Toxigenic Fungus
Stachybotrys chartarum (Ehrenb. ex Link)
Hughes (= Stachybotrys atra Corda)(19) is
one of several environmental fungi that
produce very potent compounds toxic to
humans and animals. The symptoms of
farmworkers exposed to the agriculturally
important fungi are well described and for
S. chartarum include nasal and tracheal
bleeding (in contrast to the alveolar bleed-
ing discussed above), skin irritation, and
alterations in white blood cell counts
(20-22). Both toxic and inflammatory
mechanisms appear to be involved.
S. chartarum produces satratoxin G
and H and roridin, the most potent mem-
bers of a large family of trichothecenes
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(23). Although these specific toxins have
not been as extensively studied as the
trichothecenes deoxynivalenol and T-2
toxin, their mechanism of toxicity is
thought to be very similar or the same.
High-dose exposure to deoxynivalenol
causes emesis and myocardial and gastroin-
testinal hemorrhages; lower exposures
cause damage to the immune system,
affect the appetite center ofthe brain, and
alter neurotransmitter levels (24-27).
Primarily because of the immunotoxicity
ofdeoxynivalenol, there are guidelines on
the amount of this mycotoxin allowed in
wheat in the United States and Canada
(28). Studies on the effects of inhalation
exposure of another trichothecene, T-2
toxin, demonstrated that effects from
inhalation were much greater (> 10-fold)
than by injection (29). Trichothecenes
bind to a single binding site on 60s ribo-
somes and directly inhibit initiation, elon-
gation, or termination ofprotein synthesis,
depending upon which trichothecene is
bound (30). Most of the investigation of
trichothecenes has been supported by the
U.S. Department of Defense because of
the possible use ofthese toxins as chemical
warfare agents (31,32).
Other toxins produced by S. chartarum
include phenylspirodrimanes, inhibitors
of complement activation, especially C5
(33); cyclosporin, an immune suppres-
sant targeting T-lymphocytes (34); and
stachybocins, a newly recognized class of
mycotoxins that are endothelin receptor
antagonists (35). The S. chartarum spores
are not known to germinate in the lung,
nor is there a yeast form of this fungus;
i.e., this does not appear to be an infec-
tious process, rather, inhalation produces
a mycotoxicosis.
Concern about S. chartarum in indoor
environments surfaced in the mid-1980s
(36). Documented case reports in Canada
and the United States in both residential
and nonindustrial workplaces suggested
that chronic indoor exposures were associ-
ated with a variety ofdebilitating respira-
toryand nonrespiratory symptoms (37-39),
including immune function abnormalities
(40). While still wet, the spores are sticky,
but when dry they are readily aerosolized.
Their size (4.0 - 6.0 x 7.0 - 12 pm) and
ellipsoid shape allow inhalation by stream
passage out to the distal airways (41). The
high prevalence of S. chartarum in the
Cleveland cluster area homes (65%) (4) is
unusual, as other studies in North
America have detected it in only 0.75-3%
ofthe homes (42-44).
Mouse Inhalation Studies
Acute and subacute inhalation studies
using intranasal instillation ofS. chartarum
spores with 5-week-old adult mice have
been reported. In the acute study (45),
mice were exposed to 106 spores contain-
ing satratoxin G and H or to the same dose
ofspores from a strain that produced unde-
tectable levels of these trichothecenes but
comparable levels of the phenylspirodri-
manes. The mice receiving the toxic spores
developed severe alveolar, bronchiolar, and
interstitial inflammation (neutrophils,
macrophages, lymphocytes) with luminal
hemorrhagic exudates, whereas the spores
without satratoxins induced a much milder
inflammation. In the subacute studies,
biweekly intranasal administration for 3
weeks (46) produced similar dosage-
dependent inflammation using 105 and 103
toxic spores, significantly milder inflamma-
tion with 105 nontoxic spores, and no
inflammation with 103 nontoxic spores.
These numbers of spores are reasonable
given the inefficiency of inhalation from
nasal instillation and because 6.3 x 104
colony-forming units/m3 of S. chartarum
were found in the bedroom of one of the
Cleveland infants. All ofthe mice failed to
develop IgG antibodies to S. chartarum.
This is not surprising for those receiving
the toxic spores, as trichothecenes are
known to kill macrophages ingesting the
spores (47) and even humans who become
ill after exposure to S. chartarum often do
not develop IgG or IgE anti-Stachybotrys
antibodies (38-40). The pulmonary
inflammation seen with spore inhalation is
in contrast to previous studies (48) with
aerosolized solutions of trichothecenes.
The latter produced no respiratory tract
inflammation; rather, cell necrosis and lysis
were seen in spleen, thymus, and intestines.
Because the latter organs were spared in the
spore studies, it appears that the fungal
spores may be slow-release reservoirs that
tend to limit the toxic effects to the more
immediate locale. There are no reports in
the literature ofstudies with toxic spores or
trichothecene solutions administered by
inhalation or by ingestion to infant animals
ofany species.
Pathophysiologic Concepts
In view ofthe dinical profile ofthe disorder
in young infants and the knowledge about
the toxic actions ofS. chartarum toxins, the
following pathogenesis is suggested. The
disorder appears to be associated with the
inhalation ofS. chartarum spores containing
toxins, most notably the trichothecene
protein synthesis inhibitors, satratoxins G
and H, or roridin E (15). Because young
infant lungs are growing very rapidly, pro-
tein synthesis oftype IV collagen and other
endothelial basement membrane compo-
nents would be particularly sensitive to inhi-
bition. Thus, the release of these toxins
could lead to focal areas ofcapillary fragility.
Subsequent exposure to stresses that alter
blood flow in the lungs (e.g,. unequal
hypoxic vasoconstriction from environmen-
tal tobacco smoke, marked sympathetic
reaction to asphyxia) could lead to local
areas of increased capillary pressure and
subsequent stress hemorrhage ofthese frag-
ile capillaries. Transmural pressures insuffi-
cient to rupture normal capillaries may be
pathogenic under these conditions (49).
There are several possible explanations
for the hemosiderosis that persists for
months beyond the acute hemorrhagic
period. The capillaries may remain fragile
for a prolonged time with an increased
susceptibility to leakage even with compar-
atively minor stresses. The mouse studies
found a severe inflammatory reaction per-
sisting beyond an acute toxicity period.
This inflammation could be a source of
alveolar bleeding, either directly or
through interaction with any persisting
capillary fragility.
The nonpulmonary manifestations are
similar to those described in animals
exposed to S. chartarum and are consistent
with the immune suppressive, neurotoxic,
and hemolytic effects ofthe trichothecenes
and/or accompanying mycotoxins. One
patient in Cleveland had accompanying
P. carinii pneumonia and a transitory but
severe suppression ofhis T-cell mitogenic
response to concanavalin A and phyto-
hemagglutinin consistent with exposure to
cyclosporin. The stachybocins may con-
tribute directly to the hemorrhage by
antagonizing the vasoactive properties of
endothelin-1, a paracrine hormone
released by endothelial cells in response to
hypoxia (50).
Summary
An epidemiologic investigation of
pulmonary hemorrhage in infants in
Cleveland found an association with
exposure to S. chartarum and other air-
borne fungi. Exposure to environmental
tobacco smoke was an additional risk fac-
tor in the presence of S. chartarum.
Further studies are needed to determine
whether the fungal association is causal.
Logical pathophysiologic concepts do
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derive from a comparison of the clinical
profile of these infants and the known
actions ofmycotoxins from S. chartarum,
notably the trichothecenes satratoxins G
and H. Sufficient association and ratio-
nale exist to institute public health pre-
vention measures as reflected in recent
recommendations from the American
Academy of Pediatrics (51). Prevention
has begun in the Cleveland cluster area. It
appears that this is a newly recognized dis-
order that is a subsegment of idiopathic
pulmonary hemosiderosis.
Recommendations
The home environments of infants with
idiopathic pulmonary hemorrhage should
be investigated for water damage and toxi-
genic fungi. Such infants should be
excluded from environments containing
toxigenic fungi and from environmental
tobacco smoke, as the latter appears to be a
trigger of acute hemorrhage in these
infants. Conditions ofchronic water incur-
sion into residential structures needs to be
avoided, flooding should be cleaned up
quickly and adequately prior to reoccu-
pancy, and cellulose materials should be
removed from any area that is frequently
wet. Infants who die suddenly without
known cause should have an autopsy that
includes a Prussian blue stain oflung tissue
to look for prior pulmonary hemorrhage as
indicated by the presence ofhemosiderin.
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